Latest news about Bandaram Pharma Packtech
Bandaram Pharma Packtech
28.19
+0.57(+2.06%)
Company Performance:
View Company Insights1D+2.06%
1M+0.32%
6M-14.58%
1Y-22.47%
5Y+23.48%
More news about Bandaram Pharma Packtech
13Feb 26
Bandaram Pharma Packtech Announces Q3FY26 Results Under Regulation 33 Compliance
Bandaram Pharma Packtech Limited announced its Q3FY26 financial results under SEBI Regulation 33 compliance, showing contrasting performance between standalone and consolidated operations. While standalone operations reported a net loss of Rs. 21.14 lakhs, consolidated operations achieved a net profit of Rs. 34.95 lakhs, primarily driven by subsidiary performance including VSR Paper & Packaging Limited and Craftsmart Products Private Limited.
30Jan 26
Bandaram Pharma Packtech Limited Announces Board Changes with New Director Appointment and Resignation
Bandaram Pharma Packtech Limited announced board changes effective 30.01.2026, appointing Mr. Eswar Reddy Putturu as Additional Non-Executive Independent Director for a 5-year term and accepting Mrs. Priyanka Agarwal's resignation due to personal reasons. The new director brings MBA expertise in finance and marketing, while the outgoing director also served on boards of Midland Polymers Limited and Cura Technologies Limited. All regulatory compliance requirements under SEBI regulations have been fulfilled.
14Nov 25
Bandaram Pharma Packtech Reports Q2 FY26 Loss of Rs. 34.74 Lakhs Amid Revenue Decline
Bandaram Pharma Packtech Limited reported a net loss of Rs. 34.74 lakhs for Q2 FY26, compared to a profit of Rs. 67.19 lakhs in Q2 FY25. Standalone revenue fell by 89.6% to Rs. 32.93 lakhs. Despite reducing expenses by 75.8%, the company couldn't offset the revenue decline. Half-yearly results show a total income of Rs. 109.50 lakhs and a net loss of Rs. 61.63 lakhs. Consolidated performance was slightly better with revenue of Rs. 1,372.48 lakhs and a net profit of Rs. 6.02 lakhs for Q2 FY26.
07Nov 25
Bandaram Pharma Packtech Promoters Acquire Additional Shares Through Preferential Allotment
Bandaram Pharma Packtech Limited announced a major share acquisition by its promoters. Prajitha Bandaram acquired 486,480 shares through preferential allotment on November 6, 2025. This increased the company's equity share capital from Rs. 12.00 crores to Rs. 17.97 crores. After the acquisition, the promoter group's holdings include Prajitha Bandaram (486,480 shares), Satyavathi Bandaram (1,880,000 shares), B Premsai Reddy (1,880,000 shares), and M. Seetharama Reddy (112,500 shares). The disclosure was filed under SEBI regulations for substantial acquisition of shares and takeovers.
05Sept 25
Bandaram Pharma Packtech Reappoints Chairman, Sets AGM Date for September 2025
Bandaram Pharma Packtech's board has approved the reappointment of Mr. Deepak Reddy Bandaram as Chairman and Managing Director for three years, subject to shareholder approval. The company's AGM for FY 2024-25 is scheduled for September 29, 2025, via video conference. The board also approved the Directors' Report for FY 2024-25.
Industry Peers
Dr. Lal Path Labs
Vijaya Diagnostic Centre
Metropolis Healthcare
Thyrocare Technologies
Nephrocare Health Services
Krsnaa Diagnostics
Suraksha Diagnostic
3B BlackBio DX
Health X Platform
One Global Service Provider
1,607.40
(-0.61%)
1,308.50
(+3.73%)
555.35
(+3.58%)
506.30
(-1.14%)
598.70
(-1.06%)
549.45
(+2.04%)
285.80
(-1.31%)
1,241.20
(+1.60%)
307.25
(-1.40%)
445.35
(+5.00%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
